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Abstract: Many phytochemicals are endowed with photoprotective properties, i.e., the 
capability to prevent the harmful effects of excessive exposure to ultraviolet (UV) light. 
These effects include photoaging and skin cancer, and immunosuppression. 
Photoprotection is endowed through two major modes of action: UV absorption or 
reflection/scattering; and tissue repair post-exposure. We and others have uncovered the 
photoprotective properties of an extract of the fern Polypodium leucotomos (commercial 
name  Fernblock). Fernblock is an all-natural antioxidant extract, administered both 
topically (on the skin) or orally. It inhibits generation of reactive oxygen species (ROS) 
production induced by UV including superoxide anion. It also prevents damage to the 
DNA, inhibits UV-induced AP1 and NF-κB, and protects endogenous skin natural 
antioxidant systems, i.e., CAT, GSH, and GSSR. Its photoprotective effects at a cellular 
level include a marked decrease of UV-mediated cellular apoptosis and necrosis and a 
profound inhibition of extracellular matrix remodeling. These molecular and cellular 
effects translate into long-term inhibition of photoaging and carcinogenesis that, together 
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with its lack of toxicity, postulate its use as a novel-generation  photoprotective 
nutriceutical of phytochemical origin. 
Keywords: Polypodium leucotomos extract; photoprotection; oral sunscreen; antioxidant; 
photoaging; skin cancer 
 
1. Introduction 
Modern approaches to the use of natural products in medicine include the concentration of the 
active principles in the form of lipophilic or hydrophilic extracts, which are then delivered 
systemically (in the form of pills or syrups) or topically, in the form of poultices, ointments or creams. 
Polypodium leucotomos is a tropical fern that belongs to the Polypodiaceae family [1]. This and other 
ferns belonging to the same family have value in traditional, natural medicine in South America, and 
were commonly used to make poultices to treat psoriasis and other skin disorders, although with 
variable success [2]. However, their promise as potential natural treatments for several skin disorders 
has generated an interest in several pharmaceutical companies and research groups. These efforts have 
resulted in the production of a concentrated hydrophilic extract of the leaves of Polypodium leucotomos 
(commercial name Fernblock), which is endowed with photoprotective properties. These have been 
shown in several cellular, animal and human models and studies. These studies constitute a growing 
body of knowledge that supports its wide use in the prevention of photoaging and suggests its efficacy 
as a preventive measure against UV-induced cancers.  
2. UV Radiation and the Skin: Regular Foes and Occasional Friends 
Ultraviolet (UV) photons are endowed with wavelengths 100–400 nm. For study purposes, the 
Commission Internationale de L’ Éclairage (CIE) and other international organisms classify UV 
radiation into three major subtypes, depending on the wavelength: UVA, (315–400 nm), UVB   
(280–315 nm) and UVC (100–280 nm). UVA, UVB and UVC photons can damage the skin. However, 
UVC photons are blocked in the upper layers of the atmosphere, thus they do not pose a health 
problem except in those regions where the ozone layer is weakened. It is necessary to note that very 
limited exposure to sun radiation (hence UV photons) is not only beneficial, but also required for 
human health. Indeed, UV photons catalyze the conversion of vitamin D in the skin [3]. However, 
unprotected or excessive exposure to UV photons has catastrophic consequences on the health of  
the skin, e.g., DNA damage, inflammation and immunosuppression. Most of these are due to the 
generation of ROS (Reactive Oxygen Species). With regards to DNA damage, some of the molecular 
components of the DNA absorb UVB wavelengths. UVB induce the formation of cyclobutane 
pyrimidine dimers (CPD, especially thymine-thymine) and pyrimidine-pyrimidone dimers [4,5]. These 
UV byproducts cause immunosuppression [6] and carcinogenesis [7]. UV-mediated isomerization of 
trans urocanic acid (trans-UCA) induces immunosupression [8]. In addition, UVA photons can mutate 
the DNA directly through ROS-induced oxidative damage. ROS produced this way indirectly promote Int. J. Mol. Sci. 2011, 12  8468 
 
the generation of 8-hydroxy-2’-deoxyguanosine (8-oxo-dG) [9] which is considered a bona fide 
marker of DNA oxidative damage [10]. 
UV photons also induce skin erythema, vasodilation and elevated blood flow, activation of 
endothelial cells and expression of pro-inflammatory markers, which causes leukocyte recruitment of 
immune cell infiltration [11–13]. Amplification of the immune response also occurs due to apoptotic 
bodies accumulated in the skin caused by ROS-induced cell death [14,15]. An apparently contradictory 
effect is the induction of UV-mediated immunosuppression and immunological tolerance. UV induces 
a marked decrease in the numbers of Epidermal Langerhans cells (eLCs), which causes Th1 clonal 
anergy [16].  
The molecular basis of most of these effects is related to oxidation and local generation of ROS 
formation in the skin [17,18]. Continued exposure to UV photons overwhelms the endogenous 
antioxidant mechanisms causing local oxidative stress. ROS induce oxidative damage through several 
mechanisms: one is the peroxidation of fatty acids integral to the plasma and nuclear membranes, 
promoting membrane flip-flop and contributing to cellular apoptosis; ROS can also induce DNA 
damage (see previous paragraph); finally, they can oxidize proteins, which correlates with accelerated 
aging [19].  
In summary, ROS are one of the major causes of environment-mediated skin aging (“photoaging”).  
3. Fernblock: A Multi-Pronged Approach to Photoprotection 
3.1. Formulation and Biological Disposition 
Fernblock is but one of a newer generation of natural photoprotective preparations that can be  
used either systemically (oral intake) or topically, by application on the skin. A major part of its 
photoprotective properties rely on its antioxidant properties due to its high phenolics content. Fernblock’s 
phenolics moiety include mostly benzoates and cinnamates, e.g., caffeic and ferulic acids [20]. Caffeic 
acid inhibits UV-induced peroxide and nitric oxide (NO) formation, whereas ferulic acid quenches  
UV photons [21,22]. Interestingly, PL efficiently scavenges superoxide anion, similar to superoxide 
dismutase [23,24]. These have been shown to inhibit skin erythema induced by sun exposure [25]. 
Fernblock also contains different types of biological acidic molecules, e.g., quinic, shikimic, glucuronic, 
malic coumaric, and vanillic acids; and monosaccharides (mainly fructose and glucose) [26].  
In vitro and in vivo studies on the pharmacology and biological disposition of Fernblock have 
revealed that its toxicity is negligible even at high doses [26], which further substantiates its use as an 
oral, systemic photoprotector. It is also readily absorbed through the skin, thus being employed as a 
direct local photoprotector [27]. The photoprotective dose in healthy humans is 7.5 mg/kg [28,29]. 
Topically, erythema was inhibited using 0.1% (weight/volume) PLE [24]. 
3.2. Molecular, Cellular and Clinical Evidence of the Photoprotective Properties of Fernblock 
The extract that constitutes the basis of Fernblock (PL) has been analyzed thoroughly to reveal the 
molecular mechanisms through which it endows photoprotection. A summary of these effects is shown 
in Table 1.  
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Table 1. Summary of the photoprotective effects of PL. 
  Effect Reference 
DNA 
Prevents formation of cyclobutane pyrimidine dimmers;  [30] 
Inhibits basal oxidative damage (marker, 8-hydroxy-2’-
deoxyguanosine); 
[30] 
Blocks damage to mitochondrial DNA.  [31] 
Inflammation 
Prevents sunburn and erythema;  [24,27,29] 
Blocks TNFα, iNOS, AP-1, NF-κB; [32] 
Inhibits expression of COX-2;  [30] 
Prevents apoptosis.  [32,33] 
Immunosuppression 
Blocks t-UCA isomerization;  [34] 
Enhances natural antioxidant systems;  [35] 
Prevents depletion of Langerhans cells; 
Preserves LC function. 
[27,29,35] 
[36] 
Other cellular effects 
Blocks lipid peroxidation;  [37] 
Inhibits cytoskeletal disarray and MMP expression and 
activation. 
[38,39] 
3.2.1. DNA Photoprotection 
Administered in oral form, PL inhibits DNA damage and mutagenesis. PL prevented the   
UV-induced accumulation of cyclobutane pyrimidine dimers in a mouse model [30] and also in a 
small-sample clinical study with healthy human volunteers [29]. This may be due to an improved 
function of the DNA repair systems, perhaps due to decreased oxidative damage [40]. It also reduced 
basal oxidative damage, as shown by the reduction in the percentage of 8-hydroxy-2’-deoxyguanosine-
positive cells [30]. These effects likely result in the observed improvement. Finally, another small-sample 
clinical study has revealed that PL decreases UVA-dependent mitochondrial DNA damage as 
evidenced by decreased “common deletion” (CD) [31], which is a mitochondrial marker of chronic 
UVA radiation in ﬁbroblasts and keratinocytes [41].  
3.2.2. Anti-Inflammatory Activity 
There is also evidence of the anti-inflammatory properties of PL. PL prevented sunburn and 
erythema in UV-treated human skin [24,27,29], and also in psoralen-UVA (PUVA)-based   
therapy [28], which is often used in the treatment of psoriasis, vitiligo and other inflammatory skin 
conditions [42,43]. The molecular basis of its anti-inflammatory properties can be explained in terms 
of its ability to suppress the expression of pro-inflammatory molecules and markers, e.g., TNFalpha 
and iNOS [32], among others. This is consistent with its ability to block the transcriptional activation 
of AP-1 and NF-κB induced by UV radiation [32]. Importantly, PL inhibits UV-induced expression of 
COX-2 [30]. This is important as COX-2 induces the synthesis of PGI2, which is a potent inducer of 
vasodilation and inhibits platelet aggregation [44]. Together, these effects account for decreased 
leukocyte extravasation and presence of mast cells in the irradiated area [29]. PL also inhibits 
apoptosis and cell death of the cells that populate the layers of the skin, e.g., fibroblasts and 
keratinocytes [32,33], which would otherwise result in a local inflammatory response.  Int. J. Mol. Sci. 2011, 12  8470 
 
3.2.3. Inhibition of Photoimmunosuppression 
UV radiation induces skin immunosuppression. One mechanism is by elimination of skin dendritic 
cells (Langerhans cells). These professional APC (antigen-presenting cells) are crucial mediators of the 
skin immune response, and UV promotes their disappearance from skin [45]. Another mechanism is 
through activation of suppressor T cells by cis-urocanic acid. cis-urocanic acid results from the   
UV-mediated isomerization of trans-urocanic acid, which is a natural sunscreen found mainly in the 
stratum corneum of the skin [46].  
Experiments using rodent models have revealed that PL blocks UVB-induced immunosuppression [36]. 
PL prevents the elimination of Langerhans cells induced by UV irradiation during direct UV   
exposure [35], or PUVA-therapy [28]. It also inhibits the isomerization of trans-urocanic acid into the 
cis form and prevents further photo-induced breakdown and degradation in a cell-free system [34]. 
Finally, analysis of the blood and skin of mice treated orally with PL and subsequently irradiated with 
UV revealed that PL decreased the levels of oxidized glutathione and increased the activity of the 
enzyme catalase, suggesting a positive systemic effect in the antioxidant systems, particularly in   
skin [35].  
3.2.4. Prevention of Matrix Remodeling and Other Cellular Effects 
PL exhibits a strong anti-aging effect. It prevents the morphological effects associated with 
increased oxidative stress, which include a dramatic disorganization of the microfilaments and loss of 
cell-matrix and cell-cell anchorage points [38]. Additional anti-aging effects of PL include inhibition 
of the expression and activation of several matrix metalloproteases and increased expression of an 
endogenous metalloprotease inhibitor, TIMP. Other molecules that are down-regulated during the 
onset of photoaging, such as elastin, collagen and TGF-β, are markedly stimulated by PL [39].  
UV radiation also damages the cellular membranes by inducing lipid peroxidation [47]. PL counters 
this effect and thus prevents subsequent membrane damage [37]. 
3.2.5. Anti-Skin Tumor Capability 
Several studies have documented the anti-tumor properties of different fern extracts, including   
PL [48,49]. For example, in a hairless albino mice model, PL blocked tumor formation in the skin as a 
result of exposure to UVB [50]. A number of features support the anti-carcinogenic capability of PL. 
For one, it blocks ROS formation and their effects (see above). Similarly, its anti-mutagenic properties 
also protect from immortalizing mutations leading to carcinogenesis [30]. As outlined above, PL inhibits 
the increase of COX-2 induced by UV radiation [30], which is also involved in carcinogenesis [51–53]. 
Also, PL induced activation of the tumor suppressor p53 [30]. Finally, it is interesting to note that PL 
complemented the effect of ascorbate in limiting melanoma cell growth and their ability to remodel the 
extracellular matrix through, among other effects, increasing the expression of the metalloprotease 
inhibitor TIMP-1 [54].  
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3.3. Potential Use of Fernblock in the Treatment of Pathological Skin Conditions 
3.3.1. Idiopathic Photodermatosis 
These lesions include clinical conditions that emanate from exposure of the skin to normal sunlight. 
Some examples include polymorphic light eruption (PLE), solar urticaria, chronic actinic dermatitis 
and actinic prurigo [55]. A very recent study has addressed the potential of PL to counter the 
occurrence of PLE [56]. Despite taking into account the limitations of the patient cohort and the open 
nature of the trial, this study suggests that PL has a positive effect in the treatment of PLE, which may 
be extended to other idiopathic photodermatoses.  
3.3.2. Vitiligo 
One of the most efficient methods to treat vitiligo vulgaris is narrow band (311–312 nm) UVB 
phototherapy, which stimulates melanocyte reservoirs to counter depigmentation. A double blind, 
placebo-controlled study has showed that the conjoined use of PL with narrow-band UVB (NB-UVB) 
increases the repigmentation of the head and neck area of vitiligo patients [57]. Together with its 
beneficial effect on PUVA-therapy [28,58], these studies suggest that PL may be a beneficial, general 
use adjuvant in phototherapy protocols.  
4. Fernblock: A Road to (Present and Future) Photoprotection 
Fernblock exhibits a wide array of beneficial effects and displays no significant toxicity or 
allergenic properties. Its dual route of administration, i.e., topical and oral, suggest that it is efficient as 
a preventer of UV-induced damage (taken orally before exposure), as a protector during exposure 
(both orally and topically) and also may contribute to the healing and regeneration of the skin that is 
required post-exposure. These regenerative properties also underlie its potential as an anti-aging and 
anti-cancer tool. Most of its beneficial effects are related to its antioxidant and ROS scavenging 
capability, but its ability to prevent apoptosis and block the improper ECM rearrangements that occur 
during oxidative damage suggest that its profile may extend beyond skin care and be useful as a 
systemic antioxidant tool. Further research will be aimed to study its effect in other parameters related 
to aging, e.g., telomere length and telomerase activity, etc.  
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